Generalized epilepsy has traditionally been considered a seizure of the "'whole brain.'" However, new research has challenged this longstanding idea, since carefully targeting specific brain areas ...

SK Biopharmaceutical’s Xcopri (cenobamate) met the bar in a phase 3 trial that could support the company’s ambitions of ...

Recurrent seizures are debilitating and can sometimes, be fatal. The onset and presentation of seizures vary significantly among epilepsy patients. Of more than 25 categories of seizure presentations ...

Epilepsy is a neurological (brain) condition involving recurrent seizures. There are many types of epilepsy that vary depending on where the seizures occur in the brain, how severe the seizures are, ...

NASHVILLE, Tennessee ―The retention rate for the antiseizure drug perampanel (Eisai Co, Ltd) is more than 70% for adult patients with epilepsy, new research shows. In early results from the PERPRISE ...

Epilepsy presents differently in each person. The condition has a range of symptoms that varies. Convulsions can be one sign of epilepsy. However, people often experience epilepsy without ever having ...

On September 16, SK Biopharmaceuticals announced that it has obtained positive top-line results from a Phase 3 clinical trial evaluating cenobamate ...

J Child Neurol. 2004;19(8):571-578. Patients with an isolated visually induced seizure in special circumstances, with or without a photoparoxysmal response on the EEG. This group comprises patients ...

Many people who have had a seizure do not remember it. Afterward, they may feel confused and drowsy, have a headache, or be nauseous. Doctors often call this a postictal state. Usually, the brain ...